E-LIB Suche - Ergebnisse für: Chaves-Conde, Manuel - Sprache EN

Search for persons X

Sorted by: Relevance

Sorted by: Year

1

Neoplastic appendiceal mucinous lesions: a narrative review..:

Ayala-de Miguel, Carlos ; Jiménez-Castro, Jerónimo ; Sánchez-Vegas, Adrián..
Clinical and Translational Oncology. 26 (2023) 6 - p. 1287-1299 , 2023

Link: https://doi.org/10.1007/..

2

Lenvatininb as Treatment for Naïve Patients with Aggressive..:

Garcia-Rodriguez, Sonia ; Pinillos, Guillermo Martinez ; Chaves-Conde, Manuel
Case Reports in Oncological Medicine. 2020 (2020) - p. 1-4 , 2020

Link: https://doi.org/10.1155/..

3

A genetic view of laryngeal cancer heterogeneity:

de Miguel-Luken, María José ; Chaves-Conde, Manuel ; Carnero, Amancio
Cell Cycle. 15 (2016) 9 - p. 1202-1212 , 2016

Link: https://doi.org/10.1080/..

4

Phosphorylation of gH2AX as a novel prognostic biomarker fo..:

de Miguel-Luken, María José ; Chaves-Conde, Manuel ; Quintana, Begoña...
Oncotarget. 7 (2016) 22 - p. 31723-31737 , 2016

Link: https://doi.org/10.18632..

5

MAP17 (PDZKIP1) as a novel prognostic biomarker for larynge..:

de Miguel-Luken, María-José ; Chaves-Conde, Manuel ; de Miguel-Luken, Verónica...
Oncotarget. 6 (2015) 14 - p. 12625-12636 , 2015

Link: https://doi.org/10.18632..

6

A Colorectal Cancer Susceptibility New Variant at 4q26 in t..:

Real, Luis M. ; Ruiz, Agustín ; Gayán, Javier...
PLoS ONE. 9 (2014) 6 - p. e101178 , 2014

Link: https://doi.org/10.1371/..

7

TTCC-2019-02: real-world evidence of first-line cetuximab p..:

Rubió-Casadevall, Jordi ; Cirauqui Cirauqui, Beatriz ; Martinez Trufero, Javier...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

8

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiothe..:

Burtness, Barbara ; Haddad, Robert ; Dinis, José...
http://hdl.handle.net/10668/14105. , 2019

Link: http://hdl.handle.net/10..

9

Phosphorylation of gH2AX as a novel prognostic biomarker fo..:

Jose de Miguel-Luken, Maria ; Chaves-Conde, Manuel ; Quintana, Begona...
http://hdl.handle.net/10668/19430. , 2016

Link: http://hdl.handle.net/10..

10

Phosphorylation of gH2AX as a novel prognostic biomarker fo..:

de Miguel-Luken, María José ; Chaves-Conde, Manuel ; Quintana, Begoña...
http://hdl.handle.net/10668/10071. , 2016

Link: http://hdl.handle.net/10..

11

Phosphorylation of gH2AX as a novel prognostic biomarker fo..:

Miguel-Luken, María José de ; Chaves-Conde, Manuel ; Quintana, Begoña...
Publisher's version. , 2016

Link: http://hdl.handle.net/10..

12

A genetic view of laryngeal cancer heterogeneity:

de Miguel-Luken, María José ; Chaves-Conde, Manuel ; Carnero, Amancio
http://hdl.handle.net/10668/9892. , 2016

Link: http://hdl.handle.net/10..

13

A genetic view of laryngeal cancer heterogeneity:

de Miguel-Luken, María José ; Chaves-Conde, Manuel ; Carnero, Amancio
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894505/. , 2016

Link: http://www.ncbi.nlm.nih...

14

MAP17 (PDZKIP1) as a novel prognostic biomarker for larynge..:

Miguel-Luken, María José de ; Chaves-Conde, Manuel ; Miguel-Luken, Verónica de...
Publisher's version. , 2015

Link: http://hdl.handle.net/10..

15

A colorectal cancer susceptibility new variant at 4q26 in t..:

Real, Luis M ; Ruiz, Agustín ; Gayán, Javier...
Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0101178. , 2014

Link: http://hdl.handle.net/24..

1-15

Related subjects